A way to reduce the incidence of Ventilator Associated Pneumonia (VAP) in long-term intubated patients at Tertiary care centres (THCs) to prevent prolonged stay at hospital or death.
An affordable, safer and continuous way to monitor Intracranial Pressure (ICP) in patients at THCs to prevent the high risk of infection, permanent brain damage and seizures.
An affordable (as compared to surgery) and effective (no side-effects due to medications) way to manage Parkinson’s disease in patients at THCs to prevent severe morbidity.
An effective way to prevent the onset of pressure ulcers in patients bedridden for greater than 72 hours in any setting (hospital or home).
An affordable and continuous way (compared to MRI, CT monitoring; Calcium channel blockers and triple-H therapy) to manage (monitor) cerebral arterial perfusion in patients with subarachnoid hemorrhage at THCs to prevent Delayed Cerebral Vasospasm and Delayed Ischemic Neurological Deficits (DIND).
A long-term and definitive (compared to antiepileptic drugs and corticosteroids) way to treat epilepsy (Hypoxic Ischemic Encephalitis sequelae, Lennox Gastaut Syndrome and Rasmussen Encephalitis) in children at Tertiary care centers to prevent hemispheric atrophy, severe cognitive decline, and severe generalized morbidity.
A way to improve post decompressive craniectomy prognosis in patients with moderate to severe TBI (intracranial hematomas) at THCs to prevent persistent vegetative state or death.
A better way to treat impaired cognitive function, memory loss, disorientation and aphasia in patients with Alzheimer’s Disease (AD).
An effective and reliable method to allow for visualisation and complete clearance of brain tumors in patients at tertiary care centres to avoid recurrences.
A quantifiable, portable and affordable way to assess swallowing function in post-stroke patients at Tertiary Healthcare Centres to avoid the high risk of aspiration pneumonitis /pneumonia.